Lauren Trihy
Sr. CRC
HDF Comprehensive Cancer Ctr
School of Medicine

Publications (1)

Top publication keywords:
MaleHumansHeterocyclic Compounds, 1-RingProstatic Neoplasms, Castration-ResistantTreatment OutcomeProstate-Specific Antigen

• Single-dose 177Lu-PSMA-617 followed by maintenance pembrolizumab in patients with metastatic castration-resistant prostate cancer: an open-label, dose-expansion, phase 1 trial.
  The Lancet. Oncology 2023 Aggarwal R, Starzinski S, de Kouchkovsky I, Koshkin V, Bose R, Chou J, Desai A, Kwon D, Kaushal S, Trihy L, Rastogi M, Ippisch R, Aslam M, Friedlander T, Feng F, Oh D, Cheung A, Small E, Evans M, Fong…